Oliceridine: Examining the clinical evidence, pharmacology, and contested mechanism of action of the first FDA-approved biased opioid agonist
Related Posts
Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart[...]
Green MD, Mentz RJ, Greene SJ, Hammill BG, Essien UR, Xian Y, Michos ED, Thorpe RJ Jr, Dupre ME, Mac Grory B, Chiu CT, O'Brien[...]
Talishinsky A, Ajijola OA, Khalsa SS. Autonomic Imbalance in Cardiomyopathy and Heart Failure: From Neurobiology to Precision Neuromodulation. Curr Cardiol Rep. 2025 Oct 21;27(1):144. doi:[...]